Zimmer Biomet Holdings (ZBH) Free Cash Flow Growth (1y) (2010 - 2026)
Zimmer Biomet Holdings (ZBH) Free Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn | 28.87% |
| 2 | Stryker | 128.56 Bn | 125.08 Bn | 4.50 Bn | 14.12% |
| 3 | Medtronic | 119.26 Bn | 110.04 Bn | 6.41 Bn | 0.77% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | 13.29% |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | 142.84% |
| 6 | Dexcom | 34.55 Bn | 32.61 Bn | 830.00 Mn | -11.68% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 750.00% |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | 0.40% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | -14.34% |
| 10 | Zimmer Biomet Holdings | 19.31 Bn | 18.90 Bn | 1.54 Bn | 19.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.96% |
| Mar 31, 2026 | -4.46% |
| Dec 31, 2025 | -2.68% |
| Sep 30, 2025 | 3.56% |
| Jun 30, 2025 | 3.60% |
| Mar 31, 2025 | 95.60% |
| Dec 31, 2024 | -13.47% |
| Sep 30, 2024 | 38.65% |
| Jun 30, 2024 | 26.38% |
| Mar 31, 2024 | -33.75% |
| Dec 31, 2023 | 190.71% |
| Sep 30, 2023 | -37.24% |
| Jun 30, 2023 | -17.73% |
| Mar 31, 2023 | -6.55% |
| Dec 31, 2022 | -37.31% |
| Sep 30, 2022 | 6.15% |
| Jun 30, 2022 | -22.77% |
| Mar 31, 2022 | 41.27% |
| Dec 31, 2021 | 5.22% |
| Sep 30, 2021 | 8.41% |